David D. Meek
CIK 1555337 · Chief Executive Officer · last filed 2025-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$942.6K
Companies
7
Total Filings
38
Lifetime Open-Market Net
-$642.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | Director | 34,190 | $27.57 | $942.6K | -$166.7K | 15 | 2025-06-24 |
| CGEM | Director | — | $13.70 | — | $0 | 2 | 2025-06-16 |
| Fusion Pharmaceuticals Inc. (FUSN) Delisted | Director | — | $21.55 | — | $0 | 2 | 2024-06-04 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Chief Executive Officer | 151,171 | $58.70 | $8.87M | -$321.3K | 5 | 2023-01-24 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Director | 0 | $2.19 | $0 | $0 | 6 | 2022-07-11 |
| Baxalta Inc (BXLT) Delisted | EVP and President, Oncology | 52,514 | — | — | $0 | 3 | 2016-03-07 |
| ENDOCYTE INC (ECYT) Delisted | Chief Commercial Officer | 7,500 | — | — | -$155.0K | 4 | 2014-02-10 |
Recent Filings · Page 2 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-24 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +89,379 | $0 | EDGAR |
| 2023-01-19 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −3,179 | -$134.7K | EDGAR |
| 2022-12-21 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | +30,809 | -$186.6K | EDGAR |
| 2022-07-11 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Mixed | −49,500 | -$108.9K | EDGAR |
| 2022-06-17 | QURE | Grant (A) | +9,080 | $0 | EDGAR |
| 2022-03-02 | QURE | Sell (S) | −602 | -$10.1K | EDGAR |
| 2022-02-28 | QURE | Grant (A) | +1,534 | $0 | EDGAR |
| 2022-02-15 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Mixed | — | $0 | EDGAR |
| 2022-01-19 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Grant (A) | +27,500 | $0 | EDGAR |
| 2022-01-18 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +34,057 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.